Table: Chugai Pharm -Q1 group results (IFRS)

Chugai Pharmaceutical

27/04/2023 09:00

Apr 27 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   3 months ended      3 months ended       Year to 
                  Mar 31, 2023        Mar 31, 2022     Dec 31, 2023 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              312.24              360.34                     
                   (-13.3 pct)                                      
  Operating           98.30              187.01                     
                   (-47.4 pct)        (+192.3 pct)                  
  Pretax
  Net                 73.50              131.78                     
                   (-44.2 pct)        (+177.9 pct)                  
  EPS Basic         44.68 yen           80.14 yen                   
  EPS Diluted       44.67 yen           80.09 yen                   
  Ann Div                               78.00 yen        80.00 yen  
  -Q2 Div                               38.00 yen        40.00 yen  
  -Q4 Div                               40.00 yen        40.00 yen  
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T